Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez ...

Transcarent is aligned with those who pay for healthcare and takes accountability for results - offering at-risk pricing models and transparent impact reporting to ensure incentives support a ...